SARS-CoV-2 and its ACE2 receptor

The SARS-CoV-2 virus enters the human host cell via the receptor ACE2 and uses the serine protease TMPRSS2 for S protein priming. The ACE2 usage has been shown to be crucial for transmissibility of other coronaviruses. Much research into the COVID-19 pandemic focuses on understanding the complex process of virus entry.

August 8, 2020
Open Access

Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports

Journal of Neuroinflammation
Souhel NajjarSalman Azhar
August 9, 2020
Open Access

SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities

Ishita GuptaAla-Eddin Al Moustafa
August 12, 2020

Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Silvio De FloraSebastiano La Maestra
August 11, 2020

Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1)

Molecular Biology Reports
Michele GalluccioCesare Indiveri
August 9, 2020
Open Access

The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting

International Journal of Environmental Research and Public Health
Hossein HozhabriMeysam Sarshar
August 9, 2020
Open Access

On the molecular mechanism of SARS-CoV-2 retention in the upper respiratory tract

BioRxiv : the Preprint Server for Biology
Kristina A ParisCarlos J Camacho
August 11, 2020

Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster

QJM : Monthly Journal of the Association of Physicians
Claire L Shovlin, Marcela P Vizcaychipi
August 10, 2020
Open Access

COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Roger FrutosChristian A Devaux
August 12, 2020

Advances in research on ACE2 as a receptor for 2019-nCoV

Cellular and Molecular Life Sciences : CMLS
Jie WuXiuhong Yang
August 12, 2020

Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients

Cell Journal
Najmeh SalehiMehdi Totonchi
August 8, 2020
Open Access

Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2)

Journal of Clinical Pathology
Owen WieseTahir S Pillay
August 9, 2020

Nuclear imaging of bacterial infection- state of the art and future directions

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Ilona PolvoyDavid M Wilson
August 11, 2020

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy

Mina K ChungLars G Svensson
August 12, 2020

Angiotensin-converting Enzyme 2 roles in the Pathogenesis of COVID-19

Current Hypertension Reviews
Azra KenarkoohiShahla Sohrabipour
August 11, 2020

Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus

Journal of Molecular and Cellular Cardiology
Kirk U Knowlton
August 11, 2020
Open Access

A gendered magnifying glass on COVID-19

Clinical and Molecular Allergy : CMA
Lorenzo SalvatiPaola Parronchi

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2020 Meta ULC. All rights reserved